Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Mingzhan Xue, Alaa Shafie, Talha Qaiser, Nasir M. Rajpoot, Gregory Kaltsas, Sean James, Kishore Gopalakrishnan, Adrian Fisk, Georgios K. Dimitriadis, Dimitris K. Grammatopoulos, Naila Rabbani, Paul J. Thornalley, Martin O. Weickert
Published Aug 16, 2017 · Vol. 8, No. 44 · pp. 76961-76973
Yun Hak Kim, Dae Cheon Jeong, Kyoungjune Pak, Myoung-Eun Han, Ji-Young Kim, Liu Liangwen, Hyun Jin Kim, Tae Woo Kim, Tae Hwa Kim, Dong Woo Hyun, Sae-Ock Oh
Published Aug 14, 2017 · Vol. 8, No. 40 · pp. 68381-68392
Sarah Schott, Pauline Wimberger, Barbara Klink, Konrad Grützmann, Julian Puppe, Ulrike Sophie Wauer, Daniel Martin Klotz, Evelin Schröck, Jan Dominik Kuhlmann
Published Aug 14, 2017 · Vol. 8, No. 44 · pp. 76935-76948
Christopher J. Walker, Matthew J. O’Hern, Vanida A. Serna, Takeshi Kurita, Mario A. Miranda, Caroline E. Sapp, David G. Mutch, David E. Cohn, Paul J. Goodfellow
Published Aug 12, 2017 · Vol. 8, No. 40 · pp. 68758-68768